Riferimento farmaci
Zoledronic acid
Zoledronic acid is a medicine in the class musculoskeletal. It is used for glucocorticoid-induced osteoporosis.
- Classe del farmaco: Musculoskeletal
- Indicato per: glucocorticoid-induced osteoporosis
Ultimo aggiornamento
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
In breve
- Classe del farmaco
- Musculoskeletal
- Codice ATC
- M05BA08
- Forme farmaceutiche comuni
- iniezione, infusione
- Dosaggi comuni
- 4 mg/5 ml, 5 mg/100 ml, 4 mg
- Interazioni note
- 19 (Moderata: 13 · Minore: 6)
- Nomi commerciali
- 37
- Paesi e mercati
- 5
Per cosa si usa
Come agisce
Bisphosphonate; inhibits bone resorption via actions on osteoclast activity, leading to indirect increase in bone density
Dose abituale nell'adulto (sintesi del foglio illustrativo)
Hypercalcemia of Malignancy (Zometa): No more than 4 mg IV (infused over >15 minutes) once; may be repeated in 7 days
Gravidanza e allattamento
- Gravidanza
- Unsafe No human data. In rats it caused malformations and fetal loss at about 2 times human exposure. It is stored in bone for years, so a later pregnancy may also be exposed. EU label: contraindicated in pregnancy and not recommended in women who could conceive; US: stop when pregnancy is recognised.
- Allattamento
- Unknown No data on passage into milk; infant absorption is unlikely (LactMed). EU (Aclasta): contraindicated while breastfeeding; US oncology labels: do not breastfeed during and after treatment (bone retention); Reclast: weigh benefits. LactMed: prefer an alternative, especially with a newborn.
Effetti indesiderati segnalati
- Fatigue
- Vomiting
- Nausea
- Constipation
- Anemia
- Bone pain
Controindicazioni
- Pregnancy
- All indications: Hypersensitivity, including rare cases of urticaria, angioedema, and anaphylactic reaction or shock
- Nononcologic uses: Hypocalcemia, severe renal impairment (CrCl <35 mL/min or evidence of acute renal impairment)
Chi deve prestare attenzione
- Infuse over ≥15 minutes; faster infusion increases renal toxicity
- Increased risk of osteonecrosis of jaw (advise patients against dental work); reported predominantly in cancer patients treated with IV bisphosphonates
- Risk of osteonecrosis of the jaw may increase with duration of exposure to bisphosphonates
Informare il farmacista o il medico di gravidanza o allattamento, malattie renali o epatiche, allergie e di ogni altro farmaco o integratore assunto.
Interazioni principali (19)
- Amikacin + Zoledronic acid Moderate
- Bumetanide + Zoledronic acid Moderate
- Dichlorphenamide + Zoledronic acid Moderate
- Ethacrynic acid + Zoledronic acid Moderate
- Foscarnet + Zoledronic acid Moderate
- Gentamicin + Zoledronic acid Moderate
- Human parathyroid hormone recombinant + Zoledronic acid Moderate
- Indomethacin + Zoledronic acid Moderate
- Sodium sulfate / ?magnesium sulfate / potassium chloride + Zoledronic acid Moderate
- Sodium sulfate / potassium sulfate / magnesium sulfate + Zoledronic acid Moderate
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per aprire la monografia completa di Zoledronic acid: dosi, gravidanza e allattamento, effetti indesiderati, avvertenze e tutte le interazioni.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Paediatric dosing
- Pharmacokinetics
- Patient counselling points
- Food interactions
- IV preparation and dilution
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Altri farmaci della stessa classe
Letture rapide correlate
Domande frequenti
What is Zoledronic acid used for?
Zoledronic acid is a medicine in the class musculoskeletal. It is used for Glucocorticoid-induced osteoporosis, Hypercalcemia of malignancy, Osteoporosis, Paget's disease.
What side effects have been reported with Zoledronic acid?
Fatigue, Vomiting, Nausea, Constipation, Anemia, Bone pain.
Can Zoledronic acid be taken in pregnancy or while breastfeeding?
Pregnancy: Unsafe. No human data. In rats it caused malformations and fetal loss at about 2 times human exposure. It is stored in bone for years, so a later pregnancy may also be exposed. EU label: contraindicated in pregnancy and not recommended in women who could conceive; US: stop when pregnancy is recognised. Breastfeeding: Unknown. No data on passage into milk; infant absorption is unlikely (LactMed). EU (Aclasta): contraindicated while breastfeeding; US oncology labels: do not breastfeed during and after treatment (bone retention); Reclast: weigh benefits. LactMed: prefer an alternative, especially with a newborn.
What does Zoledronic acid interact with?
MediHelp lists 19 known interactions for Zoledronic acid. Moderate: 13 · Minor: 6. The most serious include Amikacin, Bumetanide, Dichlorphenamide.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
